Ocular Therapeutix Inc (OCUL) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Ocular Therapeutix Inc (US:OCUL), trading at 8.47. In 2025, Ocular Therapeutix Inc generated $51.82 Million in revenue and -$216.89 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Ocular Therapeutix Inc is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 8.47
- Recent Revenue (2025): $51.82 Million
- Free Cash Flow (2025): -$216.89 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.